CStone Pharma Replaces Chairman Amid Huge Losses, Irregular Investment
CStone’s executive reshuffle comes after company discovers questionable investment made by finance vice president in 2021 Key Takeaways: CStone brought four products to market last year, and its losses have…
RECENT ARTICLES
-
WuXi Biologics sells vaccine plant as new U.S. law looms
2269.HK 23.65 (+0.4%) -
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK 5.91 (+0.3%)
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
No respite for RemeGen as problems and losses pile up
9995.HK 39.75 (-1.4%) 688331.SHG 48.77 (-3.2%)
- Innogen Pharma jostles for a slice of the weight-loss market
